Annual Seasonality for Inhibikase Therapeutics Inc $1.565 (+0.09, 5.74%)

NASDAQ

Inhibikase Therapeutics Inc (IKT) @ NASDAQ

Printed Thursday, 5 November '26 01:17 ADT
View All Filters
Loading...